United Therapeutics Corporation (UTHR)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 7,364,000 | 7,167,000 | 6,044,500 | 5,169,100 | 4,615,000 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $7,364,000K
= 0.00
The debt-to-assets ratio of United Therapeutics Corporation remained consistently low at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not relied heavily on debt to finance its assets during this period. A low debt-to-assets ratio generally suggests that the company has a strong financial position and is less risky in terms of solvency. It also implies that the company may have a strong ability to cover its debt obligations using its existing assets. United Therapeutics Corporation's consistent low debt-to-assets ratio over the years reflects a conservative approach to managing its capital structure and financial risk.
Peer comparison
Dec 31, 2024